Back
Stoke Therapeutics Stock Price Chart

This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
69
STOK
Stoke Therapeutics
Last Price:
$13.20
Seasonality Move:
-13.68%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and STOK is experiencing slight selling pressure.
Stoke Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 12.15 | Buy |
20-day SMA: | 11.84 | Buy |
50-day SMA: | 10.86 | Buy |
200-day SMA: | 10.55 | Buy |
8-day EMA: | 11.04 | Buy |
20-day EMA: | 7.25 | Buy |
50-day EMA: | 3.68 | Buy |
200-day EMA: | 1.04 | Buy |
Stoke Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 3.44 | Buy |
Relative Strength Index (14 RSI): | 74.32 | Buy |
Chaikin Money Flow: | -475314 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (11.45 - 12.17) | Buy |
Bollinger Bands (100): | (7.65 - 11.25) | Buy |
Stoke Therapeutics Technical Analysis
Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | Jul 17 | Jul 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Stoke Therapeutics Stock
Is Stoke Therapeutics Stock a Buy?
-
Stoke Therapeutics share price is 13.22 while STOK 8-day simple moving average is 12.15, which is a Buy signal.
-
The stock price of STOK is 13.22 while Stoke Therapeutics 20-day SMA is 11.84, which makes it a Buy.
-
Stoke Therapeutics 50-day simple moving average is 10.86 while STOK share price is 13.22, making it a Buy technically.
-
STOK stock price is 13.22 and Stoke Therapeutics 200-day simple moving average is 10.55, creating a Buy signal.
STOK Technical Analysis vs Fundamental Analysis
Buy
69
Stoke Therapeutics (STOK)
is a Buy
Is Stoke Therapeutics a Buy or a Sell?
-
Stoke Therapeutics stock is rated a BuyThe current Stoke Therapeutics [STOK] share price is $13.22. The Score for STOK is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
Stoke Therapeutics Stock Info
Market Cap:
721.8M
Price in USD:
13.22
Share Volume:
1.6M
Stoke Therapeutics 52-Week Range
52-Week High:
16.15
52-Week Low:
5.35
Buy
69
Stoke Therapeutics (STOK)
is a Buy
Stoke Therapeutics Share Price Forecast
-
What is the Stoke Therapeutics stock price today?The Stoke Therapeutics stock price is 13.22 USD today.
-
Will STOK stock go up or go down?Stoke Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Stoke Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Stoke Therapeutics is not overvalued.
Is Stoke Therapeutics Stock a Buy?
-
Stoke Therapeutics share price is 13.22 while STOK 8-day exponential moving average is 11.04, which is a Buy signal.
-
The stock price of STOK is 13.22 while Stoke Therapeutics 20-day EMA is 7.25, which makes it a Buy.
-
Stoke Therapeutics 50-day exponential moving average is 3.68 while STOK share price is 13.22, making it a Buy technically.
-
STOK stock price is 13.22 and Stoke Therapeutics 200-day simple moving average is 1.04, creating a Buy signal.
Fundamental Analysis of Stoke Therapeutics
Is Stoke Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.17 per share, an increase this year of $2.15 per share, and a decrease next year of $2.89 per share.
Technical Analysis of Stoke Therapeutics
Should I short Stoke Therapeutics stock?
-
STOK Moving Average Covergence Divergence (MACD) indicator is 3.44, suggesting Stoke Therapeutics is a Buy
-
Stoke Therapeutics Relative Strength Index (RSI) is 74.32, which suggest Stoke Therapeutics is overbought
-
The Bollinger Bands (25) for Stoke Therapeutics is (11.45 - 12.17), which suggest Stoke Therapeutics is a Buy
-
The Bollinger Bands (100) for Stoke Therapeutics is (7.65 - 11.25), which suggest Stoke Therapeutics is a Buy
* Stoke Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.